Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Endo up for auction this summer ...
View:
Post by MrMugsy on Apr 28, 2023 11:45pm

Endo up for auction this summer ...

Malvern-based Endo International is officially up for bidding. A U.S. Bankruptcy Court has approved the auction, and bidding procedures can begin at $6 billion, writes John George for the Philadelphia Business Journal

The sale hearing for this year is set for Aug. 31, in New York City. Bidders have a deadline to submit their interest by June 13.  

But ...

All 2,861 employees of Endo International must also be offered employment as part of the agreement. According to the pharmaceutical company.

Wonder if that hinders any kind of potential deal.

Interesting.

Comment by Chianchin on Apr 29, 2023 9:24am
GUD will be next if the continue with their currrent business model and the same MNGT
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities